Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Market Cap	6.30B
Revenue (ttm)	3.95B
Net Income (ttm)	397.61M
Shares Out	1.51B
EPS (ttm)	0.26
PE Ratio	15.87
Forward PE	9.12
Dividend	0.05 (1.28%)
Ex-Dividend Date	Jul 8, 2025

Volume	4,437,124
Average Volume	7,669,871
Open	3.113
Previous Close	3.113
Day's Range	3.128 - 3.150
52-Week Range	3.050 - 4.880
Beta	0.13
RSI	45.86
Earnings Date	Nov 13, 2025

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: RMDA

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.